Christopher James Stevens, Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 36,658 shares at $3.50 ($128K) on 2026-08-11, disclosed to the SEC on 2026-08-13.
Open-market sale of $128k RCKT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.